Loss of the Volume-regulated Anion Channel Components LRRC8A and LRRC8D Limits Platinum Drug Efficacy

In recent years, platinum (Pt) drugs have been found to be especially efficient to treat patients with cancers that lack a proper DNA damage response, for example, due to dysfunctional BRCA1. Despite this knowledge, we are still missing helpful markers to predict Pt response in the clinic. We have p...

Descripción completa

Detalles Bibliográficos
Autores principales: Widmer, Carmen A., Klebic, Ismar, Domanitskaya, Natalya, Decollogny, Morgane, Howald, Denise, Siffert, Myriam, Essers, Paul, Nowicka, Zuzanna, Stokar-Regenscheit, Nadine, van de Ven, Marieke, de Korte-Grimmerink, Renske, Galván, José A., Pritchard, Colin E.J., Huijbers, Ivo J., Fendler, Wojciech, Vens, Conchita, Rottenberg, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613873/
https://www.ncbi.nlm.nih.gov/pubmed/36467895
http://dx.doi.org/10.1158/2767-9764.CRC-22-0208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613873/
https://www.ncbi.nlm.nih.gov/pubmed/36467895
http://dx.doi.org/10.1158/2767-9764.CRC-22-0208

Ejemplares similares